Semaglutide · For cardiovascular protection

Semaglutide for cardiovascular protection

You have heart disease history. Will Semaglutide help your cardiovascular risk?

S-Tier Weight Loss FDA-approved

New to peptides? Start with the foundations ->

Why people use Semaglutide for cardiovascular protection

You have heart disease history. Will Semaglutide help your cardiovascular risk? The short answer: yes, this is one of the more-discussed uses for Semaglutide - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering Semaglutide for cardiovascular protection.

What the evidence says

Evidence tier: FDA-approved. FDA-approved with multiple randomized trials behind it. The strongest evidence tier in this matrix.

SELECT trial showed 20% reduction in major adverse cardiovascular events (MACE) in non-diabetics.
FDA approval for cardiovascular risk reduction in obese non-diabetic adults.
First weight-loss drug with confirmed cardiovascular outcomes data.

Protocol notes

Standard Wegovy dosing. Often coordinated with cardiology if pre-existing cardiac care.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

You start at 0.25mg once a week and step up every four weeks. Wegovy (for weight) tops out at 2.4mg weekly. Ozempic (for diabetes) tops out at 2mg weekly. One shot, under the skin, same day each week. Always with a doctor.

Typical starting dose: 0.25 mg subQ (under-the-skin shot) once weekly for the first 4 weeks. Like tirzepatide, this is a wake-up dose, not a working dose.
Typical maintenance dose: Wegovy (weight): 1.7 mg or 2.4 mg weekly. Ozempic (diabetes): 1 mg or 2 mg weekly. Many users stabilize one rung below the max if side effects bite.
Frequency: Once weekly. Same day each week.
Cycle length: Indefinite for chronic obesity or diabetes. Some weight-loss users do a 6 to 12 month run for a defined goal.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full Semaglutide directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine